AR037426A1 - Compuesto de quinolina, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento para prepararlo y compuestos de quinolina de utilidad como intermediarios en dicho procedimiento - Google Patents
Compuesto de quinolina, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento para prepararlo y compuestos de quinolina de utilidad como intermediarios en dicho procedimientoInfo
- Publication number
- AR037426A1 AR037426A1 ARP020104525A ARP020104525A AR037426A1 AR 037426 A1 AR037426 A1 AR 037426A1 AR P020104525 A ARP020104525 A AR P020104525A AR P020104525 A ARP020104525 A AR P020104525A AR 037426 A1 AR037426 A1 AR 037426A1
- Authority
- AR
- Argentina
- Prior art keywords
- prepare
- procedure
- quinoline
- pharmaceutical composition
- compound
- Prior art date
Links
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title abstract 3
- -1 QUINOLINE COMPOUND Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- FOGZSPTUEQIHNM-UHFFFAOYSA-N n-hydroxy-n-[3-methoxy-1-(quinolin-3-ylmethylsulfonyl)butan-2-yl]formamide Chemical compound C1=CC=CC2=CC(CS(=O)(=O)CC(C(C)OC)N(O)C=O)=CN=C21 FOGZSPTUEQIHNM-UHFFFAOYSA-N 0.000 abstract 1
- 238000012261 overproduction Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003248 quinolines Chemical class 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0128376.1A GB0128376D0 (en) | 2001-11-27 | 2001-11-27 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR037426A1 true AR037426A1 (es) | 2004-11-10 |
Family
ID=9926523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020104525A AR037426A1 (es) | 2001-11-27 | 2002-11-25 | Compuesto de quinolina, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento para prepararlo y compuestos de quinolina de utilidad como intermediarios en dicho procedimiento |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7038055B2 (enExample) |
| EP (1) | EP1448529B1 (enExample) |
| JP (1) | JP2005513034A (enExample) |
| AR (1) | AR037426A1 (enExample) |
| AT (1) | ATE299497T1 (enExample) |
| AU (1) | AU2002365510A1 (enExample) |
| DE (1) | DE60205035T2 (enExample) |
| ES (1) | ES2243783T3 (enExample) |
| GB (1) | GB0128376D0 (enExample) |
| TW (1) | TW200303746A (enExample) |
| WO (1) | WO2003045922A1 (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9706255D0 (en) * | 1997-03-26 | 1997-05-14 | Smithkline Beecham Plc | Novel compounds |
| DK1001930T3 (da) * | 1997-07-31 | 2003-03-24 | Abbott Lab | N-hydroxyformamidderivater som inhibitorer af matrix-metalloproteinaser |
| DE69934094T2 (de) | 1998-01-30 | 2007-06-06 | Darwin Discovery Ltd., Slough | N-hydroxyformamid-derivate |
| AU2001267468A1 (en) * | 2000-05-25 | 2001-12-03 | Smithkline Beecham P.L.C. | Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides |
-
2001
- 2001-11-27 GB GBGB0128376.1A patent/GB0128376D0/en not_active Ceased
-
2002
- 2002-11-25 DE DE60205035T patent/DE60205035T2/de not_active Expired - Fee Related
- 2002-11-25 AU AU2002365510A patent/AU2002365510A1/en not_active Abandoned
- 2002-11-25 AR ARP020104525A patent/AR037426A1/es not_active Application Discontinuation
- 2002-11-25 ES ES02790435T patent/ES2243783T3/es not_active Expired - Lifetime
- 2002-11-25 EP EP02790435A patent/EP1448529B1/en not_active Expired - Lifetime
- 2002-11-25 US US10/496,159 patent/US7038055B2/en not_active Expired - Fee Related
- 2002-11-25 JP JP2003547374A patent/JP2005513034A/ja active Pending
- 2002-11-25 AT AT02790435T patent/ATE299497T1/de not_active IP Right Cessation
- 2002-11-25 WO PCT/EP2002/013263 patent/WO2003045922A1/en not_active Ceased
- 2002-11-25 TW TW091134148A patent/TW200303746A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003045922A1 (en) | 2003-06-05 |
| ES2243783T3 (es) | 2005-12-01 |
| EP1448529A1 (en) | 2004-08-25 |
| DE60205035D1 (de) | 2005-08-18 |
| DE60205035T2 (de) | 2005-12-29 |
| JP2005513034A (ja) | 2005-05-12 |
| US7038055B2 (en) | 2006-05-02 |
| TW200303746A (en) | 2003-09-16 |
| US20050070572A1 (en) | 2005-03-31 |
| EP1448529B1 (en) | 2005-07-13 |
| AU2002365510A1 (en) | 2003-06-10 |
| GB0128376D0 (en) | 2002-01-16 |
| ATE299497T1 (de) | 2005-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP034732A (es) | Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias | |
| BR0206435A (pt) | Composto, composição farmacêutica, métodos de tratar a angiogênese em um paciente, de tratar distúrbios relacionados com kdr e proliferativos em um mamìfero, uso de um composto, e, processo para preparar compostos | |
| BRPI0409109A (pt) | novos compostos | |
| UY28339A1 (es) | Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades | |
| SE0200979D0 (sv) | New compounds | |
| TW200628161A (en) | Novel betulin derivatives, preparation thereof and use thereof | |
| WO2002068406A3 (en) | Substituted amine derivatives and their use for the treatment of angiogenesis | |
| BRPI0409227B8 (pt) | "composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)" | |
| ATE381537T1 (de) | Formanilid-derivative als beta2-adrenorezeptor- agonisten | |
| TW200745111A (en) | New compounds | |
| AR037517A1 (es) | Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria | |
| CR7743A (es) | Nuevos compuestos de oxazol y tiazol como inhibidorea del factor de crecimiento transformador (tgf) | |
| MY135218A (en) | 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases | |
| UY27872A1 (es) | Inhibidores de caspasa y usos de los mismos. | |
| CL2004000848A1 (es) | Compuestos derivados de fenacil-2-hidroxi-3-diaminoalcanos, inhibidores de la enzima betasecretasa, utiles para preparar un medicamento para tratar alzheimer, sindrome de down, hemorragia cerebral hereditaria con amiloidosis de tipo holandes, y otras | |
| ECSP045469A (es) | El uso de cianopirrolidinas sustituidas y preparaciones de combinacion que las contienen para tratar hiperlipidemia y enfermedades asociadas | |
| JO2493B1 (en) | New phenyl azatidinone with improved physical properties and methods of preparation of drugs containing it and its uses | |
| PA8603001A1 (es) | Compuestos utiles para el tratamiento de enfermedades | |
| AR037427A1 (es) | Compuesto de quinolina, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento para prepararlo y compuestos de quinolina de utilidad como intermediarios en dicho procedimiento | |
| SE0102440D0 (sv) | New compound | |
| SE0401655D0 (sv) | New compounds | |
| IT1307786B1 (it) | Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali. | |
| DOP2024000211A (es) | Compuestos heteroaromáticos bicíclicos condensados y su uso en el tratamiento del cáncer | |
| DE60228968D1 (de) | Deramciclan-enthaltende pharmazeutische zusammensetzung für die behandlung der verringerung kognitiver funktionen und/oder schäden davon | |
| UY27372A1 (es) | Derivados de bencimidazol 1-aril-2-n, s u o-sustituidos, su uso para la obtención de medicamentos y preparados farmacéuticos que contienen estos derivados |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |